Skip to main content

Parkinson’s disease Archives

Impulsivity in Parkinson’s Disease

Oct. 27, 2017—A noninvasive MRI technique may help predict a troubling side effect of common medications for Parkinson’s Disease and improve clinical treatment plans.

Read more

Health and Medicine Reporter Research


Trial to test whether DBS slows Parkinson’s progression

Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.

Read more

Health and Medicine Reporter Research Research Blog


Deep brain stimulation program marks milestones

Mar. 24, 2016—Vanderbilt Clinical Neurosciences is marking two milestones — the 20th anniversary of its deep brain stimulation (DBS) program and its 1,000th DBS procedure.

Read more

Healthcare Solutions Reporter


Neimat: Emotional disturbance is an overlooked symptom of Parkinson’s

Oct. 22, 2015—Despite benefiting from dramatic improvements in movement after deep brain stimulation surgery, patients with Parkinson’s disease can be inadequately served when physicians and researchers focus only on its motor manifestations, says a Vanderbilt neurosurgeon.

Read more

Health and Medicine Healthcare Solutions Reporter Research


Study sheds light on a ‘guardian’ protein of brain function

Feb. 19, 2015—Mitochondria not only are the cell’s main power producers, they are also the chief cooks and bottle washers.

Read more

Health and Medicine Reporter Research


Copper toxicity and Parkinson’s

Feb. 5, 2015—A genetic predisposition to Parkinson’s disease makes neurons more vulnerable to the toxicity of heavy metals such as copper.

Read more

Health and Medicine Reporter Research


New tools to probe manganese biology

Nov. 26, 2014—Vanderbilt researchers have developed tools to probe the role of the essential metal manganese in neurons, and which offer a started point for developing therapeutic agents for manganese-related neurological disorders.

Read more

Health and Medicine Reporter Research


Team takes 4-D look at brain receptor’s role

Aug. 14, 2014—Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory.

Read more

Health and Medicine Reporter Research


DBS for Parkinson’s trial moves to next level

Apr. 3, 2014—A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.

Read more

Health and Medicine Reporter Research


‘Missing link’ may spur new brain disorder drugs

Mar. 13, 2014—Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Read more

Health and Medicine Reporter Research


Amish aid study of Parkinson genetics

Nov. 11, 2013—Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.

Read more

Health and Medicine Reporter Research


Newsmakers: Vanderbilt’s teaching, research and patient care efforts are making an impact

May. 6, 2013—These stories from the past year show how Vanderbilt is making an impact, on campus and in the world.

Read more

myVU myVU News


Page 1 of 3123